BioSante Pharmaceuticals, Inc. (BPAX)

[Just the facts maam]

Found this article in the American Heart Journal

A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder

Safety trial

I don't know if the results are starting get out but there seems a definitely increase in interest. The article lays out the process and rational in easy to understand language.

I found this statement in the conclusion interesting. Don't know if it refers to future product development,expansion of the target audience or for general consumption by other researchers.

Conclusions

The BLISS study is an important and novel study for establishing the safety of LibiGel testosterone therapy in postmenopausal women with HSDD. The operational principals of this study may be applicable to conducting safety studies for other drugs in other populations with low event rates. The study has been ongoing since 2008 and has been actively enrolling and randomizing participants. The BLISS study is designed to document the efficacy and safety of LibiGel for treatment of HSDD, a common condition for which there is no FDA-approved pharmaceutical treatment in women.